Cleansing compositions.

CLEANING COMPOSITIONS

FIELD OF THE INVENTION

The present invention relates to improved cleaning compositions for use in cleaning skin surfaces. In particular, the invention is useful for cleaning facial areas of skin, and is particularly useful for cleaning various makeup products.

BACKGROUND OF THE INVENTION

Due to the wide variety of skin, hair and nail problems that consumers suffer from, consumers have long sought personal care products that can cleanse the skin, or deliver and/or deposit beneficial agents that alleviate these problems. Preferably, a facial cleanser should provide adequate cleaning efficacy to remove foundation, mascara and eyeliner. However, it is important to avoid sacrificing the products' ability to adequately cleanse the skin in favor of reducing irritation to a user. Many delivery systems sacrifice aesthetics and cleanability for stability and reduced irritation. This is particularly true when those products must be used on sensitive areas, such as the face, and even more particularly, the very sensitive regions surrounding the eyes. It is also beneficial to provide a product that gives a pleasant sensation to the user, such as having a greater sensation of moisturization, with less greasiness, and lower levels of residue. Other desirable characteristics include a cleaner feel and more softness (cushioned feel) after use.

Accordingly, it would be desirable to create such a composition that is capable of adequately cleansing the skin of a user, where the composition has a lower degree of eye and skin irritation, and that provides a pleasant after-feel.

BRIEF DESCRIPTION OF THE INVENTION

The present invention includes various cleaning compositions, and methods of using and preparing cleaning compositions. In one aspect, there is a cleaning composition that includes a fluid composition embedded in a substrate, where the fluid composition includes: a cleaning mixture that includes a first stearic ester, a second stearic ester and a branched hydrocarbon, where the first stearic ester and the second stearic ester are different from each other. Optionally, the bQA7 ίη/ΖΖΩΖ/Ε/ΥΙΛΙ cleaning compositions of the present invention may include one or more of the following: aesthetics, reduced greasiness, less eye and skin irritation, shorter drying time achieved with less force and lower cost, the amount of cleaning agents in the composition is reduced, and the cleaning compositions are allowed to be silicone-free. In some aspects, the cleaning compositions of the present invention are free of emulsifiers derived from polyisobutenyl succinic anhydride or emulsifiers derived from polyisobutylene.

As used herein, the term percentage shall refer to percentage by weight and, similarly, all quantities expressed herein shall be by weight unless otherwise indicated. As further used herein, the term "water-dispersible component" means a material that produces a uniform, transparent or opaque mixture, when combined with at least an equivalent weight of water. The term beneficial agent used in the present description includes any active ingredient to be delivered in and/or on the skin, hair or nails at the desired location, including, but not limited to, agents such as a cosmetic agent or a pharmaceutical agent. Cosmetic agent means any ingredient that is suitable for cosmetically treating, providing nutrients to, and/or conditioning hair, nails and/or skin by topical application. Pharmaceutical agent means any drug that is suitable for topical use. As used herein, medicated agents include agents capable of promoting recovery from injury and illness.

Generally, the present invention includes cleaning compositions that include one or more of the following: water, thickener(s), humectant(s), emollient(s), preservative(s), fragrance(s), excipient(s), extract(s) and regulator(s). Various combinations of the above components are useful in the present invention. The compositions may be useful in liquid or gel form, to be applied by hand, or in combination with a cloth, canvas or sponge to be applied by an applicator device.

Cleaning compositions useful in the present invention may be formulated comprising a combination of at least two emollients. As used herein, emollients refer to materials used to cleanse the skin, hair and eyelashes, prevent or relieve dryness, or to protect the skin. Examples of emollients include, but are not limited to, hydrophobic compounds such as vegetable oils, mineral oils (e.g., petrolatum), fatty esters (e.g. e.g., isopropyl palmitate, C12-C15 alkyl benzoate) including those fatty esters of glycerol and the like.

Cleaning compositions used herein include at least one oil phase and at least one aqueous phase, and may include a plurality of oil phases in addition to a separate aqueous phase. Each oil phase includes components described in the present description. When combined in a cleaning composition, the first oil phase, the optional second oil phase, and the aqueous phase provide a safe, effective and pleasant cleaner. It is understood that, in forming the cleaning composition, it is not necessary to separately form the first oil phase, second oil phase and aqueous phase, but rather the components of each of these phases can be added to each other in any desired arrangement. The designation of first oil phase, second oil phase and aqueous phase is intended to help explain and understand the components of the cleaning composition, but is not intended to designate any particular method or required steps used to form the cleaning compositions described herein. In other words, the first and second oil phases can be contained in a single oil phase.

The invention includes a fluid cleaning composition. The cleaning composition includes a first oil phase and an aqueous phase, and optionally includes a second oil phase. As mentioned above, the first oil phase and the second oil phase can form one oil phase, and do not need to be formed separately. Furthermore, the three phases do not need to be formed separately, and can be formed in a single batch or by adding any component at any time. Phase identification is simply intended to help describe the overall composition and not necessarily to describe the formation of distinct, separately formed phases.

The first oil phase includes at least three emollients, where the first emollient, second emollient and third emollient are each different from each other. The first emollient and the second emollient may be present in the same amount, or substantially the same amount. In some aspects, the first emollient may be present in an amount that is greater than the second emollient.

The first emollient may be an alkyl ester according to Formula I:

R1-R2 (I)

In Structure (I), Ri is C3 to C22, and can be linear, branched, cyclic, saturated or unsaturated. Ri can have one, two, three or four branch points. A branch point can have three bonds to other carbons and one to a hydrogen, or four bonds to other carbons. Side chains attached to a branch point can be methyl, ethyl, propyl or butyl. The branch points can be at the end of Ri (opposite the ester group) or near the ester group. Non-limiting examples include ethylhexyl, isopropyl, isopentyl, neopentyl, isohexyl, isodecyl, isododecyl and the like. Examples of linear Ri include propyl, hexyl, nonyl, decyl, and hexadecyl. Ri may contain one or two groups with heteroatoms, such as oxygen, nitrogen or sulfur, for example, hydroxy (-OH) and alkyl ether (-O-methyl, -O-ethyl and -O- Ri). Ri may contain one, two, or three double bonds, or triple bonds, or both. Ri can be synthetic, e.g. e.g., derived from petroleum, or may be derived from renewable resources, such as plant and animal material, such as triglyceride oils, or from fermentation processes, or may be derived from a mixture of resources.

R2 is a carboxylic acid that has the general structure: -O-CO-R3. R3 can have from about 12 carbons to about 22 carbons, and can be linear, branched, cyclic, saturated or unsaturated. R3 can have one, two, three or four branch points. A branch point can have three bonds to other carbons and one to a hydrogen, or four bonds to other carbons. Side chains attached to a branch point can be methyl, ethyl, propyl or butyl. The branch points can be at the end of R3 (opposite the ester group) or near the ester group. Examples of R2 with branched R3 include isododecanoate, isopentadecanoate, neopentadecanoate, isohexadecanoate, isobehenate and the like. Examples of linear R2 include e.g. e.g., laurate, myristate, stearate, behenate. R3 may contain one or two groups with heteroatoms, such as oxygen, nitrogen or sulfur; examples include hydroxy (-OH) and alkyl ether (-O-methyl, -O-ethyl and -O-Ri). Examples of R2 with a hydroxyl group on R3 are alpha-hydroxy stearate, alpha-hydroxy palmitate, and ricinoleate. R2 may contain one, two, or three double bonds, or triple bonds, or both. R2 can be synthetic, e.g. e.g., derived from petroleum, or may be derived from renewable resources, such as plant and animal material, such as triglyceride oils, or from fermentation processes, or may be derived from a mixture of resources.

The first oil phase may also include a second emollient, and the second emollient may be an ester according to Formula (I) above, where the second ester is different from the first ester. If R2 differs by zero, one or two carbons compared to R2 of the first ester, Ri of the second ester differs by at least five carbons compared to Ri of the first ester. If Ri differs by zero, one or two carbons compared to Ri of the first ester, R2 of the second ester differs by at least five carbons compared to R2 of the first ester.

The first emollient may be a stearic ester, such as an isostearate, and may include, for example, isopropyl isostearate, decyl isostearate, and hexyl isostearate. Isopropyl isostearate may be commercially available under its trade name Crodamol IPIS™. In some aspects, if decyl isostearate is used, it may be a simple ester produced using commercial isostearic acid or any of its derivatives useful for forming esters. However, in some aspects, decyl isostearate may be or include an isostearate that is formed from the esterification of an isostearic acid or any of its useful derivatives to form esters, which has been subjected to a refinement process to increase the proportion of monobranched bQR7 ίη/ΖΖΩΖ/Ε/ΥΙΛΙ molecules present in the acid compared to the unrefined (e.g., simple) acid. As used herein, the term decyl isostearate refers to a simple isostearate that has not been formed from a highly monobranched acid, while the term highly monobranched decyl isostearate refers to an ester formed from a isostearic acid having a proportion of monobranched molecules compared to simple isostearic acid.

Therefore, in some embodiments, the decyl isostearate may be a highly monobranched decyl isostearate, which is formed from an isostearic acid having an increased proportion of monobranched molecules compared to simple isostearic acid. A highly monobranched decyl isostearate comprises a decyl isostearate wherein at least about 60% by weight of the decyl isostearate molecules comprise a monobranched decyl isostearate group and less than 25% by weight of the decyl isostearate molecules comprise a branched polyalkyl isostearate group. Examples of highly monobranched decyl isostearates and methods for forming highly monobranched decyl isostearates can be found in US Patent No. 9,656,944, the contents of which are incorporated herein by reference in their entirety.

The first oil phase also includes a second emollient, where the second emollient is different from the first emollient. The second emollient may be an alkyl ester defined above and, furthermore, the second emollient may be a second stearic ester, where the second stearic ester is different from the first stearic ester. Suitable stearic esters include those defined above with respect to the first stearic esters. By way of example, the first emollient may include isopropyl isostearate, and the second emollient may include a simple decyl isostearate and/or a highly monobranched decyl isostearate. In some aspects, the second emollient may be a mixture of simple decyl isostearate and highly monobranched decyl isostearate. In embodiments where the first emollient and second emollient are a first stearic ester and a second stearic ester, the first stearic ester and the second stearic ester may be present in the same amount, or substantially the same amount. In some aspects, the first stearic ester may be present in a greater amount than the second stearic ester.

The first oil phase may also include a third emollient, where the third emollient is different from both the first emollient and the second emollient. The third emollient may also be an alkyl ester as defined above, or in some aspects, the third emollient may be a straight or branched chain hydrocarbon emollient having from 8 to 20 carbon atoms. Suitable straight or branched chain hydrocarbon emollients include, for example, decane, dodecane, tridecane, tetradecane, squalene, bQR7 ίΠ/ΖΖηΖ/Ε/ΥΙΛΙ hexadecane or isoparaffins. In certain aspects, the third emollient is a branched hydrocarbon emollient having 10 to 20 carbon atoms, such as isohexadecane, which may be available under its trade name Permethyl 101A sold by Sumitomo Corporation.

If the third emollient is a branched hydrocarbon, it may optionally have 1 to 5 branching points. A branch point can have three bonds to other carbons and one to a hydrogen, or four bonds to other carbons. Side chains attached to a branch point can be methyl, ethyl, propyl or butyl.

The third emollient may contain one or two groups with heteroatoms, such as oxygen, nitrogen or sulfur; examples include hydroxy (-OH) and alkyl ether (-O-methyl, -Oethyl and -O-propyl). Ri may contain one, two, or three double bonds, or triple bonds, or both. The third emollient may be synthetic, e.g. g., derived from petroleum, or may be derived from renewable resources, such as plant and animal material, e.g. e.g., triglyceride oils, or from fermentation processes, or may be derived from a mixture of resources.

In certain aspects, isohexadecane may have a structure according to Formula II:

bQR7 Ln/Zznz/E/YIAI

<img file="MX2022012984A_D0001.tif" />

(Π)

Ideally, each of the first and second emollients is present independently in an amount greater than the third emollient. By way of example, the first emollient may be present in an amount of about 0.5% to about 8% by weight of the composition, or about 1% to about 6% by weight of the composition, or preferably about 2% to about 4%. % by weight of the composition; The second emollient may be present in an amount of about 0.5% to about 8% by weight of the composition or about 1% to about 6% by weight of the composition, and preferably about 2% to about 4% by weight of the composition. , and the third emollient may be present in an amount of about 0.5% to about 8% by weight of the composition or about 1% to about 6% by weight of the composition, and preferably about 2% to about 4% by weight of the composition.

It may be desired that the first emollient, second emollient and third emollient be present in a desired ratio to each other. By way of example, if the first emollient is a first stearic ester, the second emollient is a second stearic ester and the third emollient is a branched hydrocarbon having 8 to 20 carbon atoms, they may be present in a weight ratio of about 4:4:2, or about 2:2:1 (first stearic ester: second stearic ester: branched hydrocarbon).

In other aspects, the first emollient, the second emollient and the third emollient may be present in approximately equal amounts by weight (e.g., approximately 1:1:1 weight ratio). However, depending on the desired feel and cleanliness, it may be preferable to modify the amounts of the three emollients. This may be particularly true when the other phases of the composition include certain components or have a particular skin feel profile. That is, the second oil phase and/or the aqueous phase can include components that provide the overall composition with a desirable skin feel profile and, therefore, the first oil phase can provide greater cleansing without the need to focus on the desirable feeling on the skin. Conversely, the second oil phase and/or the aqueous phase may include components that do not provide the overall composition with a desirable skin feel profile and therefore the first oil phase may focus more on a desirable skin feel. the skin while still providing an adequate cleansing profile.

While emollients in the first oil phase are useful in providing cleansing, it is preferred that the total cleaning composition of the present invention meets several criteria, including providing cleansing, but also being low-greasy, highly moisturizing, with less residue, less stickiness and providing a softer/cushionable feel for different types of makeup, including long-wear/waterproof makeup.

For example, in some aspects it may be preferred to have the third emollient, such as a branched hydrocarbon, present in a lower amount by weight than the first emollient and in a lower amount than the second emollient. In other embodiments, it may be preferred to have the third emollient, such as a branched hydrocarbon present in an amount that is greater than one or both of the first emollient and the second emollient. Therefore, depending on the components of the second oil phase and the aqueous phase, the components of the first oil phase can be varied to suit the cleansing and skin feel profile of the overall composition.

Therefore, in some aspects, the ratios of the three emollients can be from about 1.1:1.1:1 (first stearic ester: second stearic ester: branched hydrocarbon) to about 2:2:1 (first stearic ester: second stearic ester : branched hydrocarbon). In other aspects, particularly where the third emollient is in a greater amount than the first and second emollients, respectively, the weight ratios of the three emollients may be from about 1:1:1.1 to about 1:1:3 or bQRZ ίη/ΖΖΩΖ/Ε/ΥΙΛΙ approximately 1:1:1.3 to 1:1:1.5 (first stearic ester: second stearic ester: branched hydrocarbon). The first oil phase is present in the composition in an amount of about 2.5% to about 20% by weight of the total cleaning composition, or about 5% to about 12% by weight of the total cleaning composition, or about 7- 10% by weight of the total cleaning composition. The combined weight percentage of the first, second and third emollients may be desired to be approximately 7% by weight of the total cleaning composition.

An emollient, di-PPG-3 myristyl ether adipate, may not provide the desired effects in the present invention. As such, it may be desired that the cleaning composition described and used herein be free of di-PPG-3 myristyl ether adipate.

The composition preferably includes a second oil phase. The second oil phase may include, for example, cleaning components such as humectants, nonionic surfactants (including non-foaming nonionic surfactants), glycerides, preservatives, fragrances and the like.

The second oil phase may include one or more humectants, including aliphatic diols. Other commercially available humectants capable of providing wetting and conditioning properties to the cleaning composition are suitable for use in the present invention. If so, preferably, the humectant is present in an amount of from about 0.1 percent to about 4 percent, more preferably from about 0.5 percent to about 2 percent, and most preferably from about 0.5 percent to about 1 percent, based on the total weight of the composition. Examples of suitable non-exclusive humectants include: 1) water-soluble liquid polyols selected from the group consisting of glycerin, propylene glycol, hexylene glycol, butylene glycol, pentylene glycol, dipropylene glycol and mixtures thereof; 2) polyalkylene glycol of Formula III:

HO-(RO)b-Η (III) wherein R is an alkylene group having from about 2 to about 4 carbon atoms, and b is an integer from about 1 to about 10, such as PEG 4; 3) Formula IV methyl glucose polyethylene glycol ether:

CH3-C6H10O5—(OCH₂CH₂)c—OH (IV) bQRZ ίη/ΖΖΩΖ/Ε/ΥΙΛΙ where c is an integer from about 5 to about 25;

4) urea; 5) fructose; 6) glucose; 7) honey; 8) lactic acid; 9) maltose; 10) sodium glucuronate and 11) mixtures of these.

The second oil phase may also include one or more nonionic surfactants, including essentially non-foaming nonionic surfactants. An illustrative suitable essentially non-foaming ionic surfactant includes, for example, a mixture of fatty acid esters and sucrose. The mixture of fatty acid esters and sucrose may include sucrose combined with fatty acids such as stearic acid, lauric acid, myristic acid, oleic acid, palmitic acid and combinations of one or more of these. One such desirable mixture of fatty acid esters and sucrose is sucrose cocoate, which is commercially available under the trade name Tegosoft® LSE, available from Evonik Industries.

Essentially non-foaming means that the surfactant, when used with the composition of the present invention, has a column height of less than about 20 mm, determined by the Ross-Miles foam generation test. See 18 (I.) Oil &amp; Soap 99-102 (1941) (Ross-Miles Test), which is incorporated herein by reference. The cleaning composition and personal care system can be rinsed with water or removed with a cloth. It is preferred that any non-foaming nonionic surfactants used in the cleaning compositions described herein can be rinsed with water or do not require rinsing at all. In some embodiments, it may be useful to use as a non-foaming nonionic surfactant a mixture of sorbitan stearate and sucrose cocoate, available from Croda under the trade name Arlacel 2121. The non-foaming nonionic surfactant may be present in any desired amount and, in some aspects, is present in an amount of about 0.1% to about 2% by weight of the total cleaning composition, or may be present in an amount of about 0.50% to about 0.75% by weight of the total cleaning composition.

In addition to the emollients described above, the cleaning composition may include polymeric emulsifiers. Polymeric emulsifiers that may be useful include glycerides or triglycerides, including, for example, caprylic/capric triglyceride or PEG-6 caprylic/capric glyceride. As used herein, the term polymeric emulsifier refers to those compounds capable of emulsifying systems, whereby the polymeric emulsifiers have a molecular weight of at least about 5000 and are preferably block copolymers having a hydrophilic portion. and a hydrophobic portion. Surprisingly, when used in effective amounts to emulsify the personal care system, the polymeric emulsifiers did not cause significant burning in the eyes, that is, when the emulsifier-containing composition was used in the eye area by 80 consumers, no more than about 5% of those users expressed discomfort around the bQRZ Ln/Zznz/E/YIAI eye area. Other examples of suitable non-exclusive polymeric emulsifiers include polyethylene glycol dipolyhydroxystearate-30 available from Croda under the trade name Cithrol DPHS; dimethicone copolyol, which is available from Goldschmidt Chemical Corporation under the trade name Abil EM® 90; substituted acrylates such as those available from The Goodrich Corporation under the trade name Pemulen®; and mixtures of these. The polymeric emulsifier(s) may be present in any desired amount and, in some aspects, is present in an amount of about 0.1% to about 2%. by weight of the total cleaning composition, or may be present in an amount of about 0.75% by weight of the total cleaning composition.

The second oil phase may also include preservatives or mixtures of preservatives. Suitable preservatives include components such as ethylhexylglycerin, dehydroacetic acid, benzoic acid, phenoxyethanol, polyaminopropyl biguanide, chlorphenesin, PEG4 laurate, iodopropynyl butylcarbamate and mixtures thereof. The preservative may be present in any desired amount and, in some embodiments, is present in an amount of about 0.01% to about 2% by weight of the total cleaning composition, or may be present in an amount of about 0.1 to about 1 % by weight of the total cleaning composition. In one aspect, the preservative mixture includes chlorphenesin and phenoxyethanol.

The second oil phase may also include fragrances or fragrance mixtures. Fragrances may include essential oils, or aroma compounds, fixatives, extracts, and vitamins and solvents. The fragrance may be present in any desired amount and, in some aspects, is present in an amount of about 0.01% to about 1% by weight of the total cleaning composition, or may be present in an amount of about 0.1% to about 0.2% by weight of the total cleaning composition.

The second oil phase is present in an amount of about 1% to about 10% by weight of the total cleaning composition, or may be from about 2.5% to about 5% by weight of the total cleaning composition.

The first and second oil phases may be formed together to make a single oil phase, or may be formed as separate components of the cleaning composition. The designation of a first and second oil phase is not intended to require the separate formation of these two oil phases. When processing the total cleaning composition, it may be desired to process the two oil phases separately, or the two oil phases may be processed as a single phase, the order of addition of the components being variable.

The composition includes an aqueous phase. As with the first and second oil phases, the aqueous phase does not necessarily need to be processed as a separate and distinct phase as the first and/or second oil phase. The aqueous phase is present in the greatest amount compared to the first and second oil phases, and may be present in an amount of about 75% to about 95% by weight of the total cleaning composition, or about 80% to about 85 % by weight of the total cleaning composition. The aqueous phase includes water or other suitable carrier. The water can be used in an amount of about 75% to about 90% by weight of the final composition, or more preferably about 80% to about 88% by weight of the final composition.

The first oil phase, second oil phase or the aqueous phase may additionally include one or more thickeners, which may be hydrophilic thickeners. Examples of suitable hydrophilic thickeners include, but are not limited to, carbomers available from BF Goodrich under the trade name Carbopol ® ETD 2020 (INCI: Acrylates/C10-C30 alkyl acrylate cross-linked polymer), Carbopol® Ultrez 10 NF Polymer (INCI: Carbomer), acrylate copolymers and cross-linked acrylate polymers, hydroxyethylcellulose modified with cetyl ether groups available from Hercules under the trade name Natrosol® Plus, cross-linked polyvinylmethyl ether/maleic anhydride (PVM/MA) polymer with decadiene available from International Specialty Products under the trade name Stabileze® QM, and copolymers and mixtures thereof, where carbomers are preferred. Examples of non-exclusively suitable acrylate copolymers include acrylate copolymers available from Rohm &amp; Haas under the trade name Aculyn® 33, acrylates/aminoacrylates copolymer available from National Starch &amp; Chemical Company under the trade name Structure Plus, acrylates copolymer /steareth-20 itaconate available from National Starch &amp; Chemical Company under the trade name Structure 2001, acrylates/ceteth-20 itaconate copolymer available from National Starch &amp; Chemical Company under the trade name Structure 3001, acrylates/steareth-20 methacrylate copolymer available from Rohm &amp; Haas under the trade name Aculyn® 22, and copolymers and mixtures thereof. Carbopol ETD 2020 is called carbomer interpolymer thickener and is preferred in the present invention. The thickener may be used in an amount of about 0.05% to about 0.50% by weight of the final composition, or from about 0.12% to about 0.18% by weight of the final composition.

The aqueous phase may also include a regulating agent. Suitable buffering agents may include, for example, such as citrate buffer, phosphate buffer, lactate buffer, gluconate buffer, and sodium hydroxide. The regulating agent(s) may be present in any desirable amount to achieve the desired pH. In some aspects, the buffering agent may be a mixture of 20% sodium hydroxide and water or other solvent. The regulating agent may be present in an amount of about 0.01% to about 0.5% by weight of the final composition, or more preferably about 0.2% by weight of the total cleaning composition.

In some aspects, the invention includes a cleaning composition comprising or consisting essentially of the first oil phase, the second oil phase, and the aqueous phase. It is preferred that the aqueous phase be present in the greatest amount by weight in the cleaning composition. It is also preferred that the first oil phase is present in an amount by weight that is greater than the second oil phase. The present invention may include a concentrated mixture, in which all three phases are present, but the amount of water is considerably reduced, where the concentrate can be prepared and maintained separately with water added at a later date. The use of concentrates in this fashion can be particularly useful for manufacturing and shipping purposes, particularly where the final composition (with water) is prepared in a separate location from the other components.

The compositions described herein are useful for removing various cosmetic products from the skin of users, and in particular, are useful for removing mascara, foundation, lipstick and eyeliner effectively and without remaining heavy or greasy residue. . Mascara is a notoriously difficult cosmetic material to remove from the skin, as it is deposited from high levels of film formers and includes a relatively high level of hydrophobic materials. Additionally, the mascara includes a high level of dark carbon pigments, giving it a dark color. Additionally, since mascara is typically applied to the eyes or eyelashes, cleansing requires light, gentle pressure and non-flat application. Eyeliner presents its own challenges in removing, as it includes titanium dioxide, iron oxide, mica, silica, and a higher concentration of pigments/colorants, which can be more difficult to remove. Additionally, as with mascara, eyeliner is often applied to the eyes or ocular region, and cleanup requires a gentle, lower-pressure, non-flat application. Makeup base also presents some difficulty, since it is typically an emulsion and can include silicones, which causes it to remain on the skin. Currently, cosmetics are geared toward 24-hour use, where the cosmetic remains on the user's skin for an extended period of time. These long-lasting, waterproof cosmetics have high transfer resistance, making them difficult to remove.

Particularly, it is preferred to provide a material that effectively and sufficiently removes these three cosmetic materials. Additionally, it is preferred to provide a composition that does not leave an oily or greasy residue on the surface of the skin, as such oily cleansers can be difficult to remove and can leave the user feeling dirty. Furthermore, it is important that the cleansing composition provides little or no irritation to the skin, particularly the eyes. A soft, pleasant feel to the user's skin during and after use is also desired. The present invention provides a cleaning composition having desirable characteristics defined in the present invention, while also providing adequate cleaning capabilities.

Another embodiment of the present invention is directed to a personal care system that comprises, consists of or essentially consists of, based on the total weight of the personal care system, a) a first oil phase; b) a second oil phase; and c) an aqueous phase. The personal care system may be used as a liquid or gel composition, applied to the skin using the user's hands or other tool. Optionally, the personal care system may be soaked or embedded in a substrate, such as a cloth or other application tool, where the user can simply remove the cloth or other application tool from a package and use the cloth or other application tool. to achieve cleanliness. In preferred embodiments, the cleaning composition is soaked into an individual cloth, and the user can use that cloth to clean the user's skin. Individual wipes may be packaged in a dispenser that includes a plurality of wipes, or they may be packaged in a dispenser that includes a single wipe. Desirable substrates include cloths described in more detail below.

Additionally, the personal care system and cleaning composition may optionally contain one or more beneficial agents, or pharmaceutically acceptable salts thereof. As used herein, the term beneficial agent includes any active ingredient that will be delivered in and/or on the skin, hair or nails at a desired location, such as a cosmetic agent or a pharmaceutical agent. Cosmetic agent means any ingredient that is suitable for cosmetically treating, providing nutrients to, and/or conditioning hair, nails and/or skin by topical application. Pharmaceutical agent means any drug that is hydrophobic or hydrophilic in nature, and suitable for topical use. As used herein, medicated agents include agents capable of promoting recovery from injury and illness. The beneficial agent(s), if used, may be included in any of the first oil phase, the second oil phase or the aqueous phase, if compatible with the other components of the selected phase.

Beneficial agents useful herein may be classified by their therapeutic benefit or their postulated mode of action. However, it should be understood that the beneficial agents useful herein, in some cases, may provide more than one therapeutic benefit or act through more than one mode of action. Therefore, the particular classifications provided in the present description are made for convenience and are not intended to limit the beneficial agents to the application(s) particularly listed. Furthermore, the compounds, which are identified below as suitable for use as beneficial agents, may be used in an amount above the amount that may be used for other purposes in the cleaning composition or personal care system.

bQR7 Ln/Zznz/E/YIAI

Examples of suitable beneficial agents include, but are not limited to, depigmentation agents; reflective; film-forming polymers; humectants; amino acids and their derivatives; antimicrobial agents; allergy inhibitors; anti-acne agent; anti-aging agent; anti-wrinkle agents, antiseptics; analgesics; antitussives; antipruritics; local anesthetics; anti-hair loss agents; hair growth promoting agents; hair growth inhibiting agents, antihistamines such as Mandragora Vernalis, Tanacetum Parthenium and the like; anti-infectives such as Acacia Catechu, Aloe Barbadensis, Convallaria Majalis, Echinacea, Eucalyptus, Mentha Piperita, Rosa Canina, Sassafras Albidum and the like; inflammation inhibitors; antiemetics; anticholinergics; vasoconstrictors; vasodilators; wound healing promoters; peptides, polypeptides and proteins; deodorants and antiperspirants; medicinal agents; skin emollients and skin moisturizers; skin firming agents, vitamins; tanning agents; skin lightening agents; antifungals, such as Centaurea Cyanus, Kalmia Latifolia and antifungals for foot preparations; depilatory agents; shaving preparations; external analgesics; perfumes; counterirritants; hemorrhoidal; insecticides; poison ivy dermatitis products; poison oak dermatitis products; burn products; anti-diaper rash agents; heat rash agents; vitamins; amino acids and their derivatives; herbal extracts; retinoids; flavonoids; perception agent; antioxidants; skin conditioners; hair lighteners; chelating agents; cell renewal enhancers; coloring agents; sunscreens, the active ingredients described in US Patent No. 6,063,397, which is incorporated herein by reference, anti-edema agents, collagen enhancers, and mixtures thereof.

Examples of suitable anti-edema agents include, but are not limited to, natural bisabolol, synthetic bisabolol, and mixtures thereof.

Examples of suitable vasoconstrictors include, but are not limited to, horse chestnut extract, prickly ash, and mixtures thereof.

Examples of suitable anti-inflammatory agents include, but are not limited to, benoxaprofen, gotu kola, bisabolol, feverfew (whole), feverfew (parthenolide free), green tea extract, green tea concentrate, hydrogen peroxide, lycopene including Lyc -o-Pen available from LycoRed Natural Products Industries, Ltd., oat oil, chamomile, and mixtures of these.

Examples of collagen enhancers include, but are not limited to, vitamin A, vitamin C, and mixtures thereof.

Examples of suitable skin tightening agents include, but are not limited to, dimethylaminoethanol (DMAE).

bQ«7 ίη/77Ω7/Β/ΥΙΛΙ

Examples of suitable antipruritics and skin protectants include, but are not limited to, oatmeal, beta-glucan, feverfew, soy and derivatives thereof, baking soda, colloidal oatmeal, surfactant-based colloidal oatmeal cleanser, Anagallis Arvensis, Oenothera Biennis, Verbena Officinalis and the like. These antipruritics may be used in an amount, based on the total weight of the cleaning composition, of about 0.01 percent to about 40 percent, and preferably of about 1 percent to about 5 percent.

As used herein, colloidal oat flour is a powder obtained by grinding and subsequent processing of whole oat grain that meets US standards for oats no. 1 or no. 2. Colloidal oatmeal has the following particle size distribution: no more than 3 percent of the total particles exceeding 150 micrometers in size and no more than 20 percent of the total particles exceeding 75 micrometers in size. Examples of suitable colloidal oatmeals include, but are not limited to, Tech-O available from Beacon Corporation, and colloidal oatmeals available from Quaker.

Examples of suitable reflectors include, but are not limited to, mica, alumina, calcium silicate, glycol dioleate, glycol distearate, silica, sodium magnesium fluorosilicate, and mixtures thereof.

Suitable film forming acetyl tyrosinamide, zinc pyrithione, coal tar, benzoyl peroxide, selenium sulfide, hydrocortisone, sulfur, menthol, pramoxine hydrochloride, tricetylmonium chloride, polyquaternium 10, panthenol, panthenol triacetate, vitamin A and derivatives thereof, vitamin B and derivatives thereof, vitamin C and derivatives thereof, vitamin D and derivatives thereof, vitamin E and derivatives thereof, vitamin K and derivatives thereof, keratin, lysine, arginine, hydrolyzed wheat proteins, hydrolyzed silk proteins, octyl methoxycinnamate, oxybenzone, minoxidil, titanium dioxide, zinc dioxide, retinol, erthromycin, tretinoin, and mixtures of these.

One type of beneficial agent includes therapeutic components that are effective in the treatment of dandruff, seborrheic dermatitis and psoriasis, as well as the symptoms associated with them. Examples of these suitable agents include, but are not limited to, zinc pyrithione, anthralin, shale oil and derivatives thereof, such as sulfonated shale oil, selenium sulfide, sulfur; salicylic acid; coal tar; povidone-iodine, imidazoles such as ketoconazole, dichlorophenyl imidazolodioxalan, which is commercially available from Janssen Pharmaceutica, NV, under the trade name Elubiol, clotrimazole, itraconazole, miconazole, climbazole, tioconazole, sulconazole, butoconazole, fluconazole, miconazole nitrate and any possible stereoisomer, and derivatives thereof; piroctone olamine (Octopirox); selenium sulfide; Ciclopirox Olamine; antisoriasis agents such as bQR7 Ln/Zznz/E/YIAI vitamin D analogues, for example, calcipotriol, calcitriol and tacaleitrol; vitamin A analogues, such as vitamin A esters, for example, vitamin A palmitate, retinoids, retinols and retinoic acid; corticosteroids such as hydrocortisone, clobetasone, clobetasol butyrate, propionate and mixtures of these.

The amount of beneficial agent that may be combined with the cleansing or emulsion composition may vary depending on, for example, the ability of the beneficial agent to penetrate through the skin, hair or nail, the specific beneficial agent chosen, the particular benefit desired. , the sensitivity of the user to the beneficial agent, the state of health, age and the condition of the skin, hair and/or nails of the user, and the like. In short, the beneficial agent is used in a safe and effective amount that is an amount high enough to provide a desired benefit to the skin or nails or to modify a certain condition to be treated, but low enough to avoid serious side effects, in a reasonable risk-benefit ratio within the scope of sound medical judgment. If included, a beneficial agent may be present in the cleaning composition or personal care system in an amount based on the total weight of the composition/system, from about 0.01 percent to about 5.0 percent and, preferably from about 0.01 percent to about 2.0 percent, and more preferably from about 0.01 percent to about 1.0 percent.

Optionally, commercially available detergent thickeners, which are capable of imparting suitable viscosity to the conditioning compositions, are suitable for use in this invention. If used, the detergent thickener should be present in the compositions in an amount sufficient to raise the Brookfield viscosity of the composition to a value of between about 500 to about 10,000 centipoise. Examples of suitable detergent thickeners include, but are not limited to: polyethylene glycol mono- or diesters of Formula V.

HO-(CH2CH₂O)zH (V) where z is an integer from about 3 to about 200;

fatty acids containing from about 16 to about 22 carbon atoms; fatty acid esters of ethoxylated polyols; ethoxylated derivatives of mono- and diesters of fatty acids and glycerin; hydroxyalkyl cellulose; alkylcellulose; hydroxyalkyl alkyl cellulose; and mixtures of these. More specifically, suitable detergent thickeners include, but are not limited to, behenalkonium chloride; cetyl alcohol, quaternium-46, hydroxyethylcellulose, cocodimonium chloride, polyquaternium-6, polyquaternium7, quaternium-18, PEG-18 glycerol oleate/cocoate, a bQRZ copolymer blend ίη/ΖΖΩΖ/Ε/ΥΙΛΙ acrylates/steareth-50 acrylate , laureth-3 and propylene glycol, which is commercially available from Goldschmidt under the trade name Antil 208, a mixture of cocamidopropyl betaine and glyceryl laurate, which is commercially available from Goldschmidt under the trade name Antil HS60, a mixture of propylene glycol, PEG 55 and propylene glycol oleate, which is commercially available from Goldschmidt under the trade name Antil 414 liquid, and mixtures of these. Preferred detergent thickeners include polyethylene glycol aster, and more preferably PEG150 distearate, which is available from the Stepan Company of Northfield, III., or from Comiel, SpA of Bologna, Italy, under the trade name PEG 6000 DS.

The cleaning composition described above can be prepared by combining the desired components in a suitable container and mixing them under any desired condition, in any conventional mixing means well known in the art, such as a mechanically stirring propellant, paddle, and the like. . The processing may include the separate steps of forming the first oil phase, forming the second oil phase and forming the aqueous phase, followed by combining the first oil phase, second oil phase and aqueous phase together in any desired order to produce the composition. final cleaning. Alternatively, the cleaning composition can be formed by forming the first and second oil phases as a single oil phase, where the order of addition of the components is variable, and then that single oil phase can be combined with the aqueous phase, which is form separately. Alternatively, the cleaning composition may be formed by combining the components of the first oil phase, the second oil phase and the aqueous phase into a single composition, where the order of addition of the components is variable.

The cleaning composition may be provided in a container in the form of a liquid, gel or cream, whereby a user may apply it to the skin with the hand or a cloth, cloth, canvas or other device, or alternatively the composition may be soaked or soaked. on a cloth or a plurality of canvases or cloths, whereby the composition can be applied to the skin by passing the canvas, cloth or other device.

Since the composition will be applied to the face and is preferably used to remove cosmetic materials, it may be preferred that the composition can be soaked into a canvas or cloth, and is provided to the user in this form. The user then removes the soaked cloth from a suitable airtight packaging, and applies it directly to the skin. Therefore, a system or package may include a plurality of wipes in a resealable package, where each wipe has been soaked in or contains a cleaning composition of the present invention. In other aspects, an individual cloth may be contained in its own airtight package or container, where the package may be discarded after using the cloth contained therein. The bQR7 ίη/ΖΖΩΖ/Ε/ΥΙΛΙ cloths are preferably disposable and include degradable components, making them ecological and healthy. Wipe materials may include, for example, natural, biodegradable or synthetic fibers or filaments (e.g. wool, silk, jute, hemp, cotton, linen, sisal or ramie) or synthetic fibers or filaments (e.g. e.g., rayon, cellulose ester, polyvinyl derivatives, polyolefins, such as polyethylene and polypropylene, polyamides, such as nylon 6, nylon 6,6, or polyesters, such as polyethylene terephthalate and polybutylene terephthalate), or combinations of these. These nonwoven materials are generally described in INDA's NONWOVEN FABRICS HANDBOOK (1999) for nonwoven substrates and their manufacturing methods. One particular substrate that may be useful is a nonwoven hydroentangled nonwoven material made from a blend of 20% rayon 1.7 dtex, 40% polyester (PET) 1.3 dtex, and 40% polyester (PET) 1.7 dtex. The basis weight of the substrate may vary, but generally ranges from about 20 grams per square meter to about 500 grams per square meter, for example, from about 50 grams per square meter to about 150 grams per square meter. The cloth substrates may be of any desired size and, in some aspects, may have any desired area, including about 2-10 inches long and about 2-10 inches wide, more preferably about 7-8 inches long. and approximately 7-8 inches wide. Other suitable cloth materials include those described in document no. EP 1 283 019 Bl, US Patent No. 9,622,944 and U.S. Patent Application no. 2016/0367102, the full descriptions of each of which are incorporated herein by reference in their entirety.

In some aspects, the composition is provided to a user in a liquid dispensing bottle or container, where the user applies the composition to a cloth or other applicator device, and the user uses that applied composition applicator to clean the skin. The composition may be sold in a dispensing bottle by itself or may be sold in a kit where the package includes a dispensing bottle with the composition therein and a plurality of applicator devices, such as cloths or balls.

The present invention includes not only the cleaning composition described above, but also includes a method of using the cleaning composition described above. The method includes applying an effective amount of the composition to the skin, including facial skin and skin near the eyes, and cleansing the skin with the composition. The composition may be applied to the skin by hand or by use of an applicator, such as a cloth, wet wipe, sponge, brush and the like. The composition can be applied while the skin is wet or dry, and can be removed from the skin with a cloth, rinsed, or the skin can be allowed to dry after applying the composition. It is particularly preferred that the composition be applied to the skin by means of a pre-soaked cloth, and allowed to dry on the skin without subsequent washing or cleaning by the user. The user can discard the used cloth. The invention described herein may be practiced in the absence of any component, ingredient or step not specifically described herein, or may include additional components or steps not expressly described herein.

As noted above, the present invention is directed to compositions that can be used to remove a variety of cosmetics from the surface of a user's skin effectively and efficiently. The compositions of the invention should be able to remove, for example, foundation, lipstick, eye shadow, lip liner, eyebrow pencil, pomade, blush, mascara, concealer, highlighter and/or eyeliner effectively. . Furthermore, the compositions of the invention may be substantially free of silicones, if not completely free of silicones.

The present invention will be better understood by means of the following examples, which are illustrative in nature and are not intended to be limited to any specific combination of elements.

Examples

The compositions and cleansing products described herein not only effectively remove desired makeup products from the skin, but also provide a number of beneficial features to the user. Such desirable characteristics include, for example, leaving a non-greasy feel to the applied skin, having a reduced or eliminated level of burning (such as burning in the eye), having a soft/cushiony feel, leaving a lower level of residue, and leaving the feeling of hydrated skin.

The following non-limiting examples demonstrate the effectiveness of the present invention.

Example 1: Pure emollient evaluation tests

Each emollient was tested individually in vitro following the Pure Emollient Assessment Instrument testing protocols, and was tested in vivo using the Pure Emollient Assessment Phase protocols, detailed below. Pure emollients were evaluated for effectiveness based on effectiveness in removing makeup (e.g., foundation, eyeliner, and mascara), skin feel, and cost. As used herein, the term pure refers to a sample that includes the emollient without other added components. The pure emollient test may include the emollient embedded or dispersed on/in a cloth substrate, as described below.

bQA? ίη/ζζηζ/Β/γίΛΐ

Example 1A: in vitro tests for evaluating pure emollient

Each emollient was tested in vitro for cleansing effectiveness in removing foundation (Revlon ColorStay™ Foundation 450 Mocha), eyeliner (L'Oréal Paris Infallible Never Fail Eyeliner, Black 511), and mascara ( LashBlast Fusion Waterproof Mascara 885 Very Black from CoverGirl).

In vitro testing was carried out using a Sheen Wet Abrasion Exfoliating Tester (REF 903/PG) and an X-rite spectrophotometer (Hunter Labscan Kramer (delta E measurement).

1. Four silicone strips were prepared for each emollient sample.

2. Each makeup formulation was applied to a 4 cm x 2 cm rectangular area on its individual silicone strip (one makeup formulation per silicone strip) and allowed to dry overnight.

3. 400 g weights were placed in the Sheen Wet Abrasion Exfoliating Tester and the accompanying materials were cleaned.

4. Readings were taken from the silicone strips after drying overnight using the spectrophotometer to establish a reference color level.

5. A 500 microliter emollient was applied to the makeup applied on the silicone strip, and spread over the area (back and forth) using a finger applicator for 15 seconds.

6. A 500 microliter emollient was applied to the wipe material, an embossed hydroentangled nonwoven material made from a blend of 20% rayon 1.7 dtex, 40% polyester (PET) 1.3 dtex, and 40% polyester (PET) 1.7. dtex (this resulting cloth is called sample substrate)

7. An exfoliation test was performed for each sample by rubbing the sample substrate with embedded emollient along the sample for a predetermined number of passes:

to. Makeup base: 5 passes

b. Eyeliner: 3 passes

c. Mascara: 30 passes

8. A reading was taken from each silicone strip after the peel test using the spectrophotometer and the resulting color level was determined. The net color change measured between the first spectrophotometer reading and the second spectrophotometer reading is called Delta E.

bQRZ ίη/ΖΖΩΖ/Ε/ΥΙΛΙ

Example IB: in vivo pure emollient evaluation tests

Each emollient was also tested in vivo for effectiveness in removing foundation (Revlon Colo rStay™ Foundation 450 Mocha), eyeliner (L'Oréal Paris Infallible Never Fail Eyeliner, Black 511) and mascara (LashBlast Fusion CoverGirl 885 Very Black Waterproof Mascara).

The general in vivo testing procedure employs a protocol that can be described as follows:

• Two panels of human individuals were used: P1 and P2 • Three circles 1 to 1.5 apart were drawn on the volar forearm of the two panels.

• Makeup formulations were applied to the circles (0.001 g of foundation, 0.002 g of eyeliner and 0.015 g of mascara) and allowed to dry for 45 minutes.

• A photo was taken of the uncleaned dirty circle.

• Approximately 0.015-0.020 g of pure emollient was applied and wiped with a sample substrate embossed back and forth for 15 seconds • Wiped once with a cotton pad and a photograph of the cleaned circle was taken.

• It was cleaned a second time with a cotton pad and a second photo of the cleaned circle was taken.

• Panelists were asked to rank the top 5 samples from 1-5 for their cleaning effectiveness, where a rating of 1 considered the most effective cleaning product, and a rating of 5 considered the least effective cleaning product, those below of the first five were not classified.

Following the in vitro and in vivo procedures described above, several pure emollients were tested to determine their cleaning effectiveness; Table 1 below shows the results of such in vitro and in vivo test result. It is noted that the combination of PEG-20 glyceryl triisostearate and isohexadecane was not tested in vivo as it was determined that PEG-20 glyceryl triisostearate does not contribute to makeup removal when evaluated as a single emollient. Additionally, the polymeric ester (sold as ModiSurf Lift by Croda) was not tested in vitro due to its primary application in home care and domestic space. PPG-3 benzyl ether ethylhexanoate was additionally tested in a separate consumer study; However, this composition was not pursued.

bQR7 ίη/77Π7/Ε/ΥΙΛΙ

Table 1: Results of the efficacy evaluation of pure emollient bPRZ ίη/ΖΖΩΖ/Ε/ΥΙΛΙ

<td>Emollient name</td><td colspan="3">In vitro (net change in Delta E)</td><td colspan="3">In vivo (subjective)</td>

<td></td><td>Makeup base</td><td>Eyeliner</td><td>Mask</td><td>Makeup base</td><td>Eyeliner</td><td>Mascara</td>

<td>PEG-20 glyceryl triisostearate + isohexadecane</td><td> -14.66</td><td> -15.06</td><td> -0.325</td><td></td><td></td><td></td>

<td>Isopropyl isostearate</td><td> -14.31</td><td> -15.84</td><td> -0.38</td><td> 4</td><td></td><td> 2</td>

<td>Isohexadecane</td><td> -10.69</td><td> -13.98</td><td> -1.4</td><td> 3</td><td> 2</td><td> 1</td>

<td>Decyl isostearate (e) isostearyl isostearate</td><td> -3.65</td><td> -14.46</td><td> -0.375</td><td></td><td></td><td></td>

<td>PPG-3 Isostearyl Methyl Ether</td><td> -10.99</td><td> -13.61</td><td> 0.02</td><td> 1</td><td></td><td></td>

<td>PPG-3 Benzyl Ether Myristate</td><td> -3.07</td><td> -4.95</td><td> -0.1</td><td></td><td> 4</td><td></td>

<td>PPG-3 Benzyl Ether Ethylhexanoate</td><td> -0.24</td><td> -11.07</td><td> -0.24</td><td> 2</td><td> 5</td><td> 5</td>

<td>di-PPG-2 Mireth-10 adipate</td><td> 1.93</td><td> -11.75</td><td> 0.3</td><td></td><td> 3</td><td></td>

<td>Myristyl ether di-PPG-3 adipate</td><td> -0.59</td><td> -1.01</td><td> 0.165</td><td></td><td> 1</td><td></td>

<td>Diisocetyl dodecanedioate</td><td></td><td></td><td></td><td></td><td></td><td> 4</td>

<td>Polymeric ester</td><td></td><td></td><td></td><td> 5</td><td></td><td> 3</td>

The above tests illustrated that isopropyl isostearate, isohexadecane and 5-decyl isostearate (decyl isostearate (e) demixed isostearyl isostearate) performed consistently well in cleaning efficacy and showed good skin feel. Based on the promising test results, these three emollients were selected as the main base pure emollients for further testing, which are described below.

Example 2: pure emollient mixture tests

Various emollients were mixed in equivalent proportions (1:1:1 by weight of active emollient) and tested for cleansing effectiveness and skin feel. Emollients tested, in various mixtures, included isopropyl isostearate (sold as Crodamol™ IPIS), diisostearyl adipate (sold as Liquiwax™ DISA), PPG-3 isostearyl methyl ether (sold as Arlamol™ LST), ethylhexanoate. PPG-3 benzyl ether ethyl (sold as Crodamol™ SFX), decyl isostearate (e) isostearyl isostearate (sold as Crodamol™ SSA), PPG-3 benzyl ether myristate (sold as Crodamol™ STS), myristyl ether di-PPG-3 adipate (sold as Cromollient™ DP3 -A), dioctyldodecyl dodecanedioate 10 (sold as Liquiwax™ DIADD).

Various emollient mixtures were tested in vitro and in vivo to determine their effectiveness in removing Revlon ColorStay™ 450 Mocha foundation), eyeliner (L'Oréal Paris Infallible Never Fail Eyeliner, Black 511), and mascara (LashBlast). Fushion Waterproof Mascara 885 Very Black by CoverGirl). The in vivo tests performed follow the procedures described in Example 1 above. The mixture effectiveness results are described in Table 2 below.

bQ«7 ίη/ζζηζ/Ε/γίΛΐ

Table 2: Results of the effectiveness evaluation of the pure emollient mixture

<td>emollient mixture</td><td colspan="2">1/7 k/Z/o (net change in Delta E)</td><td colspan="2">In vivo (subjective)</td>

<td></td><td>Makeup base</td><td>Mask</td><td>Makeup base</td><td>Mask</td>

<td>Crodamol™ IPIS + Liquiwax™ DISA + Crodamol™ STS</td><td> 9.7</td><td> 10.3</td><td>Rated no. 1 and no. 2 for 2 panelists</td><td>Rated no. 1 for 1 panelist, no. 2 by another panelist, among the last 5 for 2 panelists</td>

<td>Crodamol™ IPIS + Liquiwax™DIADD + Liquiwax™ DISA</td><td> 9.3</td><td> 11.3</td><td>Rated among the last 5</td><td>Rated in the top 5 by 3 panelists</td>

<td>Crodamol™ IPIS + Liquiwax™ DIADD + Crodamol™ STS</td><td> 10.4</td><td> 12.3</td><td>Rated no. 1 for 2 panelists</td><td>Rated in the top 5 by 2 and in the bottom 5 by 2</td>

<td>Crodamol™ IPIS + Cromollient™ DP3-A + Liquiwax™DISA</td><td> 9.6</td><td> 13</td><td>Among the first 5 for 3 panelists</td><td>Among the first 5 for 3 panelists</td>

<td>Crodamol™ IPIS + Liquiwax™ DIADD + Cromollient™ DP3-A</td><td> 9.2</td><td> 10.5</td><td>Among the first 5 for 2 panelists</td><td>Among the last 3 for 3 panelists</td>

<td>Crodamol™ IPIS + Cromollient™ DP3-A + Crodamol™ STS</td><td> 10.5</td><td> 8.4</td><td>Among the first 5 for 2 panelists</td><td>Among the last 5 for the 4 panelists</td>

<td>emollient mixture</td><td colspan="2">1/7 vitro (net change in Delta E)</td><td colspan="2">In vivo Csubietr/o)</td>

<td></td><td>Makeup base</td><td>Mask</td><td>Makeup base</td><td>Mask</td>

<td>Liquiwax™ DIADD + Liquiwax™ DISA + Crodamol STS</td><td> 6.9</td><td> 8.9</td><td>Average among the last ones for the 4 panelists</td><td>On average, 1 panelist placed it in the top 5</td>

<td>Liquiwax™ DIADD + Cromollient™DP3-A + Liquiwax™ DISA</td><td> 8.2</td><td> 12.5</td><td>Among the last 5 for the 4 panelists</td><td>Best option for 1 panelist, for all others in the bottom 5</td>

<td>Cromollient™ DP3-A + Liquiwax™ DISA + Crodamol™STS</td><td> 8.7</td><td> 9.9</td><td>Among the last 5 for the 4 panelists</td><td>Among the first 5 for 2 panelists, among the last 5 for 2 panelists</td>

<td>Liquiwax™ DIADD + Cromollient™DP3-A+ Crodamol™ STS</td><td> 8.3</td><td> 8.9</td><td>Best option for 1 panelist, among the last 5 for the other panelists</td><td>In the center to the last 5 for all the panelists</td>

<td>Crodamol™ IPIS + Arlamol™ LST + Crodamol™ SSA</td><td> 13</td><td> 13.5</td><td>It is done among the last 4 for the makeup base;</td><td>3 out of 4 ranked the mix in the bottom 5</td>

<td>Crodamol™ IPIS + Crodamol™ SFX + Arlamol LST</td><td> 14.5</td><td> 14.5</td><td>for 2 in the top 5; for 2 among the last 5</td><td>ranked in the bottom 5 for mascara</td>

<td>Crodamol™ IPIS + Liquiwax™ DISA + Arlamol™ LST</td><td> 14.2</td><td> 15.3</td><td>3 panelists ranked it in the top 3; 1 ranked it last</td><td>3 ranked it in the bottom 5 for mascara; 1 ranked it in the top 4 for mascara</td>

<td>Crodamol™ IPIS + Liquiwax™DIADD + Arlamol™ LST</td><td> 11.6</td><td> 13.2</td><td>3 classified it among the last 5; 1 classified it among the first 4;</td><td>2 classified it among the top 4; 2 classified it among the last 5</td>

<td>Crodamol™ IPIS + Liquiwax™ DIADD + Crodamol SFX</td><td> 14</td><td> 16.3</td><td>Everyone ranked it in the top 4</td><td>3 classified it among the last 5; 1 ranked it among the top 4;</td>

<td>Crodamol™ IPIS + Liquiwax™ DISA + Crodamol™SFX</td><td> 13.6</td><td> 15.8</td><td>2 classified it among the top 4; 2 classified it among the last 5</td><td>2 classified it among the top 4; 2 classified it among the last 5</td>

<td>Crodamol™ IPIS + Crodamol™ SSA + Crodamol™ SFX</td><td> 14.6</td><td> 16.6</td><td>3 classified it among the top 4; 1 classified it in the last 5</td><td>3 classified it among the top 4; 1 classified it in the last 5</td>

<td>Crodamol™ IPIS + Crodamol™ STS + Arlamol™LST</td><td> 14.2</td><td> 15.7</td><td>1 ranked it among the top 4; 3 classified it among the last 5</td><td>3 classified it among the top 4; 1 classified it in the last 5</td>

<td>Crodamol™ IPIS + Crodamol™ STS + Crodamol™SFX</td><td> 14.6</td><td> 15.2</td><td>Everyone ranked it in the bottom 5</td><td>2 classified it among the top 4; 2 classified it among the last 5</td>

frPR7 ίη/77Ω7/Ε/ΥΙΛΙ

<td>emollient mixture</td><td colspan="2">1/7 vitro (net change in Delta E)</td><td colspan="2">In vivo (subjective)</td>

<td></td><td>Makeup base</td><td>Mask</td><td>Makeup base</td><td>Mask</td>

<td>Crodamol™IPIS + Liquiwax™ DISA + Crodamol™ STS</td><td> 9.7</td><td> 10.3</td><td>Rated no. 1 and no. 2 for 2 panelists</td><td>Rated no. 1 for 1 panelist, no. 2 by another panelist, among the last 5 for 2 panelists</td>

Based on in vivo and in vitro testing, Liquiwax™ DISA was not continued bQR7 ίη/77Π7/Ε/ΥΙΛΙ due to lower cleansing efficacy for foundation and powder, and a perceived greasy feel. Liquiwax™ DIADD was not continued due to performance for the makeup base. Crodamol™ STS and Liquiwax™ DIADD were not continued due to performance for mascara. Cromollient™ DP3-A was not continued due to a greasy feeling on the skin. Arlamol™ LST was not continued due to performance for mascara.

The pure emollient mixture of Crodamol™ IPIS + Crodamol™ SSA + Crodamol™ SFX (i.e. isopropyl isostearate + isostearyl isostearate + PPG-3 benzyl ether ethylhexanoate) was selected as the primary emollient mixture for further formulation testing , as it showed a Delta E net exchange value of 14.6 and 16.6 for foundation and mascara, respectively in in vitro testing, and was rated no. 1 and only one panelist rated it in the bottom 5 in two separate in vivo tests for foundation and mascara.

Example 3: Compositions including variable emollient mixtures

To determine the cleaning effectiveness of compositions containing emollients, various compositions were prepared. Each composition included (i) an aqueous phase, (i) a first oil phase containing the emollient mixtures and (iii) a second oil phase. Each composition was prepared and tested to remove various makeup cosmetics (foundation (Revlon ColorStay™ Foundation 450 Mocha), eyeliner (Infallible Never Fail Eyeliner, black 511 by L'Oréal Paris) and mascara (LashBlast Fushion Waterproof Mascara 885 Very Black by CoverGirl).

The tested formulations were prepared and impregnated onto sample substrate cloths, the sample substrate being described above. The formulations were dosed at 3.7 g of lotion per g of substrate cloth. The formulations tested are set out in Table 3A below:

Table 3A: Compositions of the variable emollient mixtures in the first oil phase bQGZ Ln/Zznz/E/YIAI

<td>Component</td><td>Example 1</td><td>Example 2</td><td>Example 3</td><td>Example 4</td><td>Example 5</td><td>Example 6</td>

<td>Water</td><td>Q.S.</td><td>Q.S.</td><td>Q.S.</td><td>Q.S.</td><td>Q.S.</td><td>Q.S.</td>

<td>Emulsifiers</td><td> 1.05</td><td> 1.05</td><td> 1.05</td><td> 1.05</td><td> 1.05</td><td> 1.05</td>

<td>Preservatives</td><td> 0.7</td><td> 0.7</td><td> 0.7</td><td> 0.7</td><td> 0.7</td><td> 0.7</td>

<td>sodium hydroxide</td><td> 0.18</td><td> 0.18</td><td> 0.18</td><td> 0.18</td><td> 0.18</td><td> 0.18</td>

<td>Hexylene glycol</td><td> 1.0</td><td> 1.0</td><td> 1.0</td><td> 1.0</td><td> 1.0</td><td> 1.0</td>

<td>PEG-6 Caprylic Capric Glycerides</td><td> 0.75</td><td> 0.75</td><td> 0.75</td><td> 0.75</td><td> 0.75</td><td> 0.75</td>

<td>Isopropyl isostearate</td><td> 3.34</td><td> 5.00</td><td> 3.34</td><td> 5.00</td><td> -</td><td> 3.34</td>

<td>Myristyl ether di-PPG-3 adipate</td><td> 3.33</td><td> 2.5</td><td> -</td><td> -</td><td> 5.00</td><td> 3.33</td>

<td>Diisostearyl adipate</td><td> 3.33</td><td> 2.5</td><td> -</td><td> -</td><td> -</td><td> 3.33</td>

<td>Decyl isostearate (e) isostearyl isostearate</td><td> -</td><td> -</td><td> 3.33</td><td> 2.5</td><td> -</td><td> -</td>

<td>PPG-3 Benzyl Ether Ethylhexanoate</td><td> -</td><td> -</td><td> 3.33</td><td> 2.5</td><td> 2.5</td><td> 2.5</td>

<td>PPG-3 Isostearyl Methyl Ether</td><td> -</td><td> -</td><td> -</td><td> -</td><td> 2.5</td><td> 2.5</td>

<td>Isopropyl myristate</td><td> -</td><td> -</td><td> -</td><td> -</td><td> -</td><td> 1.0</td>

Two panels of human subjects then evaluated the cloths, following the 5 procedures described below:

• Three circles 1 to 1.5 apart were drawn on the volar forearm of the two panels.

• Makeup formulations were applied to the circles (0.001 g of makeup base, 0.002 g of eyeliner and 0.015 g of mascara) and allowed to dry for 10 minutes.

• Each substrate-impregnated cloth sample (Example 1 - Example 6) was prepared and provided to the subjects.

• Panelists were asked to clean the area 3 times with the cloth and evaluate the samples individually. Each sample was ranked with ratings of 115 7, where a rating of 1 is the best or most desirable cloth composition, and a rating of 7 is considered the least desirable cloth composition.

Table 3B: Efficacy test in wVode of the bQRZ ίη/ΖΖΠΖ/Β/ΥΙΛΙ compositions

<td></td><td>Panel 1</td><td>Panel 2</td>

<td>Composition</td><td>In vivo efficacy test (subjective visual evaluation)</td><td>In vivo efficacy test (subjective visual evaluation)</td>

<td>Example 1</td><td> 4</td><td> 6</td>

<td>Example 2</td><td> 5</td><td> 3</td>

<td>Example 3</td><td> 1</td><td> 1</td>

<td>Example 4</td><td> 2</td><td> 4</td>

<td>Example 5</td><td> 3</td><td> 1</td>

<td>Example 6</td><td> 7</td><td> 7</td>

Examples 1, 2 and 4-6 were considered not to meet optimal cleaning efficiency based on previous panel data. Although Example 3 showed sufficient cleaning efficiency and was classified and graded as no. 1, due to global requirements, this formulation was not pursued.

The present inventors also tested the individual ingredients of Crodamol™ SSA, and it was determined that the decyl isostearate in Crodamol™ SSA had greater effectiveness in cleaning efficiency for makeup. Finally, based on the examples described herein, isohexadecane was chosen for further testing, based on its ability to remove mascara as shown in the pure emollient tests above.

Example 4: Compositions of variable component ratios

Based on the results of the above purity and composition tests, other compositions were tested for effectiveness. In particular, different emollient ratios were tested to determine whether makeup removal and/or other skin feel criteria were affected by component ratios. The compositions were prepared as described in Table 4A below. The ratios given in the table refer to the weight ratios of the three emollients expressed in the table.

Table 4A: Emollient system for the first oily stage

<td>Component</td><td>emollient mixture</td>

<td>Emollient mixture 7</td><td>Isopropyl isostearate (IPIS): Decyl isostearate or highly monobranched decyl isostearate (DIS): Tween-20 (2:2:1)</td>

<td>Component</td><td>emollient mixture</td>

<td>Emollient mix 8</td><td>Isopropyl isostearate (IPIS): Decyl isostearate or highly monobranched decyl isostearate (DIS): Isohexadecane (IHD) (2:0:1)</td>

<td>Emollient mixture 9</td><td>Isopropyl isostearate (IPIS): Decyl isostearate or highly monobranched decyl isostearate (DIS): Myristyl ether di-PPG-3 adipate (DP3A) (1:1:1)</td>

<td>Emollient mix 10</td><td>Isopropyl isostearate (IPIS): Decyl isostearate or highly monobranched decyl isostearate (DIS): Isohexadecane (IHD) (2:2:1)</td>

<td>Emollient mixture 11</td><td>Isopropyl isostearate (IPIS): Decyl isostearate or highly monobranched decyl isostearate (DIS): Myristyl ether di-PPG-3 adipate (DP3A) (2:2:1)</td>

<td>Emollient mix 12</td><td>Isopropyl isostearate (IPIS): Decyl isostearate or highly monobranched decyl isostearate (DIS): Isohexadecane (IHD) (2:2:1)</td>

<td>Emollient mixture 13</td><td>Isopropyl isostearate (IPIS): Decyl isostearate or highly monobranched decyl isostearate (DIS): Isohexadecane (IHD) (1:1:1.4)</td>

Each composition was prepared and included (i) an aqueous phase, (i) a first oil phase containing the emollient mixtures and (iii) a second oil phase. The first oil phase includes a combination of three emollients, as described in Table 4A above.

Table 4B and Table 4C below show illustrative component levels of the second oil phase and the aqueous phase, respectively. The amount of the second oil phase and the aqueous phase can vary depending on the desired composition.

Table 4B: Illustrative levels of the components of the second oil phase

<td>Component</td><td>Amount (percentage by weight of the final composition)</td>

<td>Hexylene glycol</td><td> 1.00-2.00</td>

<td>Sucrose cocoate</td><td> 0.5-1.25</td>

<td>Chlorphenesin</td><td> 0.25-0.50</td>

<td>PEG-6 caprylic/capric glycerides</td><td> 0.75-3.00</td>

<td>Phenoxyethanol</td><td> 0.40-0.75</td>

<td>Fragrance</td><td> 0.06-1.00</td>

Table 4C: Illustrative aqueous phase bQ«7 ίη/ΖΖΩΖ/Β/ΥΙΛΙ

<td>Component</td><td>Quantity (percentage by weight of the final composition)</td>

<td>Water</td><td> 80-90</td>

<td>Acrylates/C10-C30 alkyl acrylate Cross-linked polymer</td><td> 0.10-0.25</td>

<td>Water, sodium hydroxide</td><td> 0.10-0.25</td>

Examples 7-14 were prepared as set forth in Table 4A, which include the three phases of the components described in Tables 4A, 4B and 4C. The tested formulations are set out in Table 4D below:

Table 4D: Compositions of variable component ratios

<td>Component</td><td>Example 7</td><td>Example 8</td><td>Example 9</td><td>Example 10</td><td>Example 11</td><td>Example 12</td><td>Example 13</td><td>Example 14</td>

<td>Water</td><td>Q.S.</td><td>Q.S.</td><td>Q.S.</td><td>Q.S.</td><td>Q.S.</td><td>Q.S.</td><td>Q.S.</td><td>Q.S.</td>

<td>Emulsifiers</td><td> 1.05</td><td> 1.05</td><td> 1.05</td><td> 1.05</td><td> 1.05</td><td> 1.05</td><td> 1.05</td><td> 1.05</td>

<td>Preservatives</td><td> 0.77</td><td> 0.77</td><td> 0.77</td><td> 0.77</td><td> 0.77</td><td> 0.77</td><td> 0.77</td><td> 0.77</td>

<td>sodium hydroxide</td><td> 0.18</td><td> 0.18</td><td> 0.18</td><td> 0.18</td><td> 0.18</td><td> 0.18</td><td> 0.18</td><td> 0.18</td>

<td>Hexylene glycol</td><td> 1.0</td><td> 1.0</td><td> 1.0</td><td> 1.0</td><td> 1.0</td><td> 1.0</td><td> 1.0</td><td> 1.0</td>

<td>PEG-6 Caprylic Capric Glycerides</td><td> 0.75</td><td> 0.75</td><td> 0.75</td><td> 0.75</td><td> 0.75</td><td> 0.75</td><td> 0.75</td><td> 1.50</td>

<td>Isopropyl isostearate</td><td> 4.0</td><td> 6.60</td><td> 3.33</td><td> 3.33</td><td> 1.67</td><td> 4.0</td><td> 4.0</td><td> 2.8</td>

<td>Decyl isostearate</td><td> 4.0</td><td> -</td><td> 3.33</td><td> 3.33</td><td> 1.67</td><td> 4.0</td><td> 4.0</td><td> 2.8</td>

<td>Isohexadecane</td><td> -</td><td> 3.40</td><td> -</td><td> 3.33</td><td> 6.68</td><td> -</td><td> 2.0</td><td> 3.4</td>

<td>Tween-20</td><td> 2.0</td><td></td><td> -</td><td> -</td><td> -</td><td> -</td><td> -</td><td> -</td>

<td>Myristyl ether di-PPG-3 adipate</td><td> -</td><td> -</td><td> 3.33</td><td> -</td><td> -</td><td> 2.0</td><td> -</td><td> -</td>

The compositions set forth in Table 4D were prepared and tested for in vitro cleaning capacity. A comparative sample was also tested, which included the cleansing composition included in the commercially available silicone-containing cleanser (Neutrogena™ Makeup Remover Cleansing Single-Use Wipe). For each composition, four experiments were carried out. White high-density polypropylene (HDPP) chips were dosed with different makeup samples, either 0.015 g of Revlon Colorstay 450 Mocha Foundation or 0.015 g of Hydro Boost Waterproof Black Mascara . The makeup was applied to a 1 inch round diameter area. The makeup dried for 1 hour.

The oil phases were combined with each other separately from the aqueous phase, and each phase was mixed at room temperature. The aqueous phase was mixed until homogenized. Once homogenized, the aqueous phase was added to the oil phase and the resulting combination was mixed.

For each composition, including the comparative composition, a sample substrate (defined above). Each sample substrate cloth, measuring 7.2 x 7.4 inches, was moistened by adding 3.7 g of formula per gram of cloth. The moistened cloths were placed in a 50 g weighted holder attached to an Instron instrument (Instr-Met Corporation, IM 1122_4585). The test parameters of the Instron instrument were: Number of cycles: 4, 50 per minute, End point 1: 6.0, End point 2: 0.0, Retention time: 3 seconds.

Images were taken with a Nikon camera (Nikon D800 with an AFMicro NIKKOR 60 mm 1:28 GED lens) at a fixed distance of 7.3 inches with an X-Pol filter. Images were taken (i) before makeup was applied, (ii) after makeup was applied, and (iii) after makeup was removed. Images were analyzed using Matlab by calculating the change in LAB values ​​between the baseline value, after adding makeup, and after removing makeup from the center of the applied makeup circle. The makeup removal percentage was calculated for each chip and is expressed in Table 5 below. It is noted that the comparative sample was analyzed several times, as in Example 13, and the various results are described below.

Table 5: Relationship tests with respect to variable emollient

<td>Formula</td><td>Emollients:</td><td>Relationship with respect to! emollient:</td><td>Mask</td><td>Eyeliner</td><td>Makeup base</td>

<td>Copolymer</td><td colspan="2">Silicone-containing cleaner</td><td> 80.7</td><td> 62.8</td><td> 77.5</td>

<td>Example 9</td><td>IPIS:DIS:DP3A</td><td> 1:1:1</td><td> 65.3</td><td> 41.1</td><td> 55.6</td>

<td>Example 12</td><td>IPIS:DIS:DP3A</td><td> 2:2:1</td><td> 58.6</td><td> 37.7</td><td> 51.8</td>

<td>Copolymer</td><td colspan="2">Silicone-containing cleaner</td><td> 80.2</td><td> 60.2</td><td> 82.2</td>

<td>Example 13</td><td>IPIS:DIS:IHD</td><td> 2:2:1</td><td> 76.9</td><td> 56.4</td><td> 76.4</td>

<td>Copolymer</td><td colspan="2">Silicone-containing cleaner</td><td> 91.9</td><td> 65.0</td><td> 69.9</td>

<td>Example 13</td><td>IPIS:DIS:IHD</td><td> 2:2:1</td><td> 90.3</td><td> 56.7</td><td> 82.1</td>

<td>Example 7</td><td>IPIS:DIS:T20</td><td> 2:2:1</td><td> 73.1</td><td> 54.1</td><td> 58.2</td>

<td>Copolymer</td><td colspan="2">Silicone-containing cleaner</td><td> 88.6</td><td> 74.5</td><td> 79.6</td>

<td>Example 8</td><td>IPIS:DIS:IHD</td><td> 2:0:1</td><td> 91.5</td><td> 76.5</td><td> 94</td>

<td>Example 11</td><td>IPIS:DIS:IHD</td><td> 1:1:4</td><td> 86.1</td><td> 85.1</td><td> 95.1</td>

<td>Example 10</td><td>IPIS:DIS:IHD</td><td> 1:1:1</td><td> 89.5</td><td> 83.9</td><td> 92.6</td>

<td>Copolymer</td><td colspan="2">Silicone-containing cleaner</td><td> 90.6</td><td> 45.5</td><td> 91.3</td>

<td>Example 14</td><td>IPIS:DIS:IHD</td><td> 1:1:1.4</td><td> 93.0</td><td> 57.4</td><td> 97.5</td>

bQRZ Ln/Zznz/E/YIAI

As shown in the in vitro measurement for the cleaning efficacy tests above, Example 13 qualified statistically equivalent to or outperformed the commercially available silicone-containing cleaner. Example 13 was determined to be the most effective cleaning system.

Example 5: Additional Composition Modifications

Example 13 above was considered promising, and some modifications were made and tested to determine the effectiveness and impact of various modifications to this formulation. The results of these modified formulations are set forth in the present description.

Example 13 was prepared with the modification that hexylene glycol and glycerox 767 were removed from this. The resulting composition was tested in vitro (using the method described in Example 1) to determine effectiveness in removing makeup. It was determined that the resulting composition decreased effectiveness in removing makeup.

Example 13 was prepared with the modification that glycerox 767 was increased to a level of 3% by weight of the composition. This modification was found to increase the makeup removal efficacy for the makeup base; however, it was found to increase the greasy feel of the skin and the overall cost of the cleansing composition.

Example 13 was prepared with the modification that Tween 20 was added at a level of 0.25%. It was found that the addition of this component increased the stability of the formulation.

Example 13 was prepared with the modification that the total amount of emollients was reduced to a level of 3.5% (while still maintaining the proportion of emollients indicated in Example 13). It was found that, at this lower level of total emollient, the resulting modified cleansing composition maintained makeup removal efficacy for all three makeups tested.

Example 13 was prepared with the modification that dimethicone/trisiloxane was added at a level of 2%. The resulting modified composition was found to improve skin feel and increase mascara removal effectiveness.

Example 13 was prepared with the modification that dimethicone was added at a level of 0.5%. The resulting composition was found to improve the skin feel of the composition.

Example 6: Emulsifiers

Various emulsifiers were tested in the formulation, specifically in Example 13. Example 13 was prepared with various emulsifiers, which are set forth in Table 6 to 5 below. The stability of the resulting formulations was tested, as well as makeup removal in vitro and/or in vivo, using the in vitro method set forth in Example 4 above and the in vivo method set forth in Example 1 above.

bPRZ ίη/ΖΖΩΖ/Ε/ΥΙΛΙ

Table 6: Emulsifier tests

<td>Emulsifier no.</td><td>Emulsifier(s)</td><td>INCI</td>

<td>1A I.B.</td><td>1A - ETD2020 + 0.5% sucrose cocoate IB - ETD2020 + 0.75% sucrose cocoate</td><td>Acrylates/C10-C30 Alkyl Acrylate Cross-Linked Polymer (ETD2020)</td>

<td> 2</td><td>Ultrez 10</td><td>Carbomer</td>

<td> 3</td><td>Aristiflex AVS</td><td>Ammonium acryloyldimethyltaurate/VP copolymer</td>

<td> 4</td><td>ETD2020 + Amfisol K</td><td>Acrylates/C10-C30 Alkyl Acrylate Cross-Linked Polymer (ETD2020) Single Tail Cationic (Amfisol K)</td>

<td> 5</td><td>Aristiflex HMB</td><td>Ammonium acryloyldimethyltaurate/beheneth-25 methacrylate cross-linked polymer</td>

<td> 6</td><td>Laponite RD</td><td>Laponite RD</td>

<td> 7</td><td>ETD2020+Procetyl AWS (solubilizer)</td><td>Acrylates/C10-C30 Alkyl Acrylate Cross-Linked Polymer (ETD2020) PPG-5-Ceteth-20 (Procetyl AWS)</td>

<td> 8</td><td>Pemulin TR-1</td><td>Cross-linked polymer of acrylates/C10-30 alkyl acrylate</td>

<td> 9</td><td>ETD2020 + 0.1% sucrose cocoate</td><td>Acrylates/C10-C30 Alkyl Acrylate Cross-Linked Polymer (ETD2020)</td>

Emulsifiers 1A and IB were found to exceed formula stability and provide strong makeup removal as well as skin feel evaluation. Emulsifier 2 was found to exceed the stability of the formula, but has weaker makeup removal than Emulsifier 1 and has a less desirable skin feel than Emulsifier 1. Emulsifier 3 did not show stability as the formula He slowly separated. Emulsifier 3 provided a strong skin feel, but showed significantly worse makeup removal than Emulsifier 1. Emulsifier 4 failed in stability as it separated quickly. Emulsifier 5 failed in stability as it separated overnight. Emulsifier 6 failed in stability as it separated quickly. Emulsifier 7 exceeded stability and was considered the most stable resulting formulation. Emulsifier 7 also passed the skin feel test, but was significantly worse at removing makeup than Emulsifier 1. Emulsifier 8 failed in stability as it separated quickly. However, Emulsifier 8 passed the skin feel test, but was not as effective in removing makeup as Emulsifier 1. Emulsifier 9 failed in stability as it separated overnight. Emulsifier 9 was tested for skin feel and passed; However, due to lack of stability, Emulsifier 9 was not tested for 10 makeup removal.